Closed MelissaBraxton closed 7 years ago
@MelissaBraxton this is what I was thinking in terms of an action plan for the analytics. It's a work in progress, but feel free to change this and add to it.
Additional information in #20
Mobile and desktop users:
Desktop users:
Note to self and @MelissaBraxton for working session Wednesday: A little birdie told me that @onezerojeremy did something similar to this for FEC.
Awesome. And I am just now reading through your first take above. Great start! Thanks so much for getting the ball rolling. Looking forward to digging in a bit more on Wednesday!
Melissa Braxton, MS User Experience Designer, 18F PhD Candidate, Human Centered Design & Engineering University of Washington, College of Engineering Cell: (415) 696-4216 https://18f.gsa.gov/
On Mon, Mar 27, 2017 at 1:36 PM, Austin Hernandez notifications@github.com wrote:
Note to self and @MelissaBraxton https://github.com/MelissaBraxton for working session Wednesday: A little birdie told me that @onezerojeremy https://github.com/onezerojeremy did something similar to this for FEC.
— You are receiving this because you were mentioned. Reply to this email directly, view it on GitHub https://github.com/18F/clinical-trials/issues/21#issuecomment-289577957, or mute the thread https://github.com/notifications/unsubscribe-auth/ATscnk4DS_3Js_M3RiWF9z7oHf5EGCzjks5rqB24gaJpZM4MO9NM .
Oh cool! 15% mobile is pretty substantial!
Do we have access to the search logs?
@onezerojeremy yes! the file they sent is here: CT.gov Feb 26 – Mar 4 analytics data
Just looking at some of the search data:
137,516 total search results new learning from team: undefined or empty searches are probably API calls
139 nivolumab 117 pembrolizumab 108 atezolizumab 103 sleep 82 avelumab 78 diabetes 73 durvalumab 71 depression 63 kte-c19 63 multiple sclerosis
Closing all issues from Phase 1
Dependent on https://github.com/18F/clinical-trials/issues/20